SEC Form 4 research
| Issuer | Menlo Therapeutics Inc. |
|---|---|
| Tickers | MNLO, YARW, VYNE |
| Reporting owners | 60 |
| Officers and directors | 5 |
| Last public filing | 2026-10-30 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-30 | 2026-10-29 | Payton Lori | A | 99,827 | $0 | Not reported |
| 2026-10-30 | 2026-10-29 | Alford Rachael | A | 89,844 | $0 | Not reported |
| 2026-10-30 | 2026-10-29 | Frey Rebecca | A | 465,857 | $0 | Not reported |
| 2026-10-30 | 2026-10-29 | Ryder Steven | A | 113,137 | $0 | Not reported |
| 2026-10-30 | 2026-10-29 | Zeronda Tyler | A | 156,115 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.